Blood pressure FROM RESULTS of the earlier studies it has been inferred that the major derangements in Chagas' disease are caused by a wide involvement of the autonomic nervous system.1' 2 In this regard, in some patients, the observed failure to increase heart rate following administration of atropine was interpreted as a functional disorder related to degeneration of the neuronal supply to the sino-atrial region of the heart.3 The importance of the autonomic nervous system in the circulatory alterations associated with the Valsalva maneuver are well known. Therefore, circulatory responses induced by the Valsalva maneuver in patients with chronic Chagas' heart disease From the Cardiac Catheterization Laboratory, Department t Phases of maneuver: I = onset of straining; II = sustained straining; Ir = recovery in blood pressure during sustained straining; III = cessation of straining; IV = overshoot of the systemic arterial pressure.
Subsequently, continuous recordings of heart rate were made during the continuous intravenous infusion of a total dose of 2.0 mg of atropine sulfate over an 8-minute period.
Results
On the basis of heart rate response to atropine, the chagasic patients have been divided in two groups. In four patients, atropine caused the expected alteration in heart rate (group I), which increased from an average of 68 (range, 60 to 78) beats/min to an average of 100 (range, 83 to 118) beats/min. In the other four patients (group II), atropine failed to increase the cardiac rate, the control averaging 93 (range, 68 to 117) beats/min as compared with 90 (range, 67 to 110) beats/min at the end of administration. These results are shown in figure 1 .
The circulatory responses to the Valsalva Our observations of the circulatory responses to the Valsalva maneuver suggest that chronic chagasic cardiac patients may respond differently when compared with normal subjects. We were able to divide these patients in two groups, in accordance to their response to atropine. Of special interest are these observations: (1) In all the patients, following the sudden fall in systemic arterial pressure (phase II), recovery in blood pressure occurred while the increased intrathoracic pressure was maintained nearly constant. In association with the blood pressure recovery both groups showed an increase in heart rate, although this seemed more distinct in group I (atropine positive). Reflex sympathetic stimulation is believed to cause the secondary rise in pressure and increase in heart rate. (2) As the strain was released, an initial decrease in arterial pressure was immediately followed by an overshoot in the systemic arterial pressure. The blood pressure changes in both groups of patients wvere similar. (3) The major difference in response of the two groups occurred in the recovery stage, after the release of the elevated intrathoracic pressure. Although the overshoot in blood pressure was closely similar in the two groups, bradycardia did not occur in group II (atropine negative).
The sudden changes in blood pressure during the different stages of the Valsalva maneuver cause reflex changes in heart rate in the opposite direction. These effects may be eliminated by drugs. '6 17 In normal subjects, (1) tetraethylammonium chloride abolishes the overshoot in arterial pressure and thus the stimulus for the reflexogenic bradycardia, and (2) atropine sulfate increases the magnitude and duration of the overshoot without the corresponding bradycardia.'7 Absence of blood pressure overshoot following release of the raised intrathoracic pressure in patients with idiopathic orthostatic hypotension'8 and in other conditions involving interruption of the autonomic nervous pathways' has been interpreted as a failure of compensatory constriction of vascular beds. The failure of subjects with cardiac abnormalities to demonstrate the normal response (overshoot and bradyeardia) to the Valsalva maneuver is believed to be due to the inability of the heart to respond to an increase in venous return with an increase in stroke volume, whether the limiting factor is primarily myocardial, pericardial, or valvular."' 14, 15 The mechanism for the absence of bradycardia in some of our patients cannot be related to the absence of overshoot in systemic blood pressure, as it is in the pathologic conditions mentioned above. Rather this response is comparable to that observed in healthy individuals following atropinization. 17 The difference in response between our two groups of patients is in agreement with the failure to increase the heart rate after administration of atropine. Furthermore, it does not appear to correlate with the clinical situation. Our own studies with chronic chagasic heart patients showed that on many occasions (1) administration of atropine sulfate during an acute elevation in systemic arterial blood pressure (induced by intravenous administration of metaraminol) was accompanied by minor or no alteration in heart rate3 and (2) a prompt decrease in systemic arterial blood pressure (induced by intramuscular administration of methacholine chloride) caused no impressive changes in heart rate.20 In both situations, comparisons were made with noncardiac patients. Therefore, it appears that the abnormal responses to the Valsalva maneuver described herein are a further indication of neuronal degeneration in the sino-atrial region of the heart.
